Global Organs-on-chips Market Outlook 2020-2030

Global Organs-on-Chips Market Analysis 2020-2030

The global organs-on-chips market is anticipated to grow with a CAGR of 36.54% over the forecast period, i.e., 2021 - 2030. Factors such as the increasing focus of pharmaceutical companies on the discovery of new drugs, followed by the rising research and development expenditure in the field of medical sciences, and the surge in advancements in organs-on-chips technology are anticipated to drive the growth of the market in the coming years. Moreover, factors such as the growing prevalence of different types of chronic diseases worldwide, such as cancer, dementia, and diabetes among others, which is driving the need for the development of advanced pharmaceutical drugs amongst the pharmaceutical organizations to treat these diseases, are anticipated to boost the market growth in the coming years. The market is estimated to garner a revenue of close to USD 770 Million by the end of 2030. Moreover, in the year 2020, the market generated a revenue of about USD 30 Million.

The global organs-on-chips market is segmented by numerous segments, which include segmentation by organ type, offering, application, end-user, and by region. By organ type, the market is segmented into lung, intestine, kidney, brain, liver, and others. By the end of 2030, the lung segment is anticipated to garner the largest revenue of more than USD 170 Million, up from a revenue of about USD 8 Million in the year 2020.

On the basis of regional analysis, the global organs-on-chips market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. By the end of 2030, the market in North America is anticipated to garner the largest revenue of close to USD 370 Million, up from a revenue of around USD 18 Million in the year 2020.

Some of the prominent industry leaders in the global organs-on-chips market that are included in our report are Emulate, Inc., CN Bio Innovations Limited, TissUse GmbH, InSphero AG, Elvesys, MesoBioTech, AxoSim, CHERRY BIOTECH, Nortis, Inc., BiomimX S.r.l., MIMETAS B.V., KYODO INTERNATIONAL INC., AGC Inc., and others.